PT886652E - Processo de solubilizacao de peptidos tensioactivos pulmonares - Google Patents

Processo de solubilizacao de peptidos tensioactivos pulmonares

Info

Publication number
PT886652E
PT886652E PT96936751T PT96936751T PT886652E PT 886652 E PT886652 E PT 886652E PT 96936751 T PT96936751 T PT 96936751T PT 96936751 T PT96936751 T PT 96936751T PT 886652 E PT886652 E PT 886652E
Authority
PT
Portugal
Prior art keywords
pulmonary
tensioactive
solubilization
peptides
protein
Prior art date
Application number
PT96936751T
Other languages
English (en)
Inventor
James V Weber
Charles F Kasulanis
Keith Sampino
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of PT886652E publication Critical patent/PT886652E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT96936751T 1995-11-20 1996-10-22 Processo de solubilizacao de peptidos tensioactivos pulmonares PT886652E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US734795P 1995-11-20 1995-11-20

Publications (1)

Publication Number Publication Date
PT886652E true PT886652E (pt) 2002-09-30

Family

ID=21725655

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96936751T PT886652E (pt) 1995-11-20 1996-10-22 Processo de solubilizacao de peptidos tensioactivos pulmonares

Country Status (17)

Country Link
US (1) US5741891A (pt)
EP (1) EP0886652B1 (pt)
JP (1) JP3856343B2 (pt)
KR (1) KR100475294B1 (pt)
AT (1) ATE216403T1 (pt)
AU (1) AU721289B2 (pt)
CA (1) CA2236164C (pt)
DE (1) DE69620801T2 (pt)
DK (1) DK0886652T3 (pt)
ES (1) ES2176503T3 (pt)
HK (1) HK1015381A1 (pt)
MX (1) MX9803978A (pt)
NO (1) NO320442B1 (pt)
PT (1) PT886652E (pt)
TW (1) TW553748B (pt)
WO (1) WO1997019108A1 (pt)
ZA (1) ZA969692B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6120795A (en) * 1996-03-27 2000-09-19 Ortho Pharmaceutical Corp. Manufacture of liposomes and lipid-protein complexes by ethanolic injection and thin film evaporation
AU5074400A (en) 1999-06-17 2001-01-09 Byk Gulden Lomberg Chemische Fabrik Gmbh Surfactant protein c esters
WO2007002465A2 (en) * 2005-06-23 2007-01-04 Rapid Pharmaceuticals, Llc Stabilizing alkylglycoside compositions and methods thereof
US20140141066A1 (en) * 2012-11-20 2014-05-22 Lipo Naturals Llc Encapsulated Ascorbic Acid Composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5260273A (en) * 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
US5272252A (en) * 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties

Also Published As

Publication number Publication date
CA2236164C (en) 2005-08-16
ES2176503T3 (es) 2002-12-01
NO320442B1 (no) 2005-12-05
HK1015381A1 (en) 1999-10-15
NO982279D0 (no) 1998-05-19
AU721289B2 (en) 2000-06-29
MX9803978A (es) 1998-09-30
WO1997019108A1 (en) 1997-05-29
US5741891A (en) 1998-04-21
JP2001527511A (ja) 2001-12-25
DE69620801T2 (de) 2002-10-10
AU7459596A (en) 1997-06-11
EP0886652A1 (en) 1998-12-30
CA2236164A1 (en) 1997-05-29
NO982279L (no) 1998-05-19
TW553748B (en) 2003-09-21
EP0886652B1 (en) 2002-04-17
DE69620801D1 (de) 2002-05-23
ATE216403T1 (de) 2002-05-15
KR19990067660A (ko) 1999-08-25
JP3856343B2 (ja) 2006-12-13
ZA969692B (en) 1998-05-19
KR100475294B1 (ko) 2005-07-28
DK0886652T3 (da) 2002-08-12

Similar Documents

Publication Publication Date Title
ES2190087T3 (es) Formulacion estabilizada de un anticuerpo.
DK0918848T3 (da) Fremgangsmåder til at behandle kræftsygdomme og patogene infektioner ved anvendelse af antigenpræsenterende celler påfyldt med RNA
PT865294E (pt) Processo para a reducao ou a manutencao de niveis reduzidos de lipidos no sangue utilizando composicoes de proteina ob
BR9509269A (pt) Processo para tratar diabetes
PT94869A (pt) Processo de preparacao de uma composicao terapeutica a base de moleculas de anticorpos anti-cd14
DE69010000D1 (de) Expression von menschlichen apolipoproteinen ai-milano in hefe.
ITMI951764A0 (it) Peptide sintetasi ingegnerizzate e loro impiego per la produzione via non-ribosomale di peptidi
DE60114996D1 (de) Senkung des serum cholesterols
ES2179942T3 (es) Un proceso para la preparacion de clorhidrato de lercanidipino.
PT886652E (pt) Processo de solubilizacao de peptidos tensioactivos pulmonares
ES2111570T3 (es) Aislamiento y purificacion de la proteina de agente tensioactivo pulmonar.
ATE140485T1 (de) Co-hydrolytsches verfahren zur herstellung von extrakten aus hefe und nicht-hefe proteinen
NZ333265A (en) Vaccine containing peroxiredoxin and/or beta-tubulin of fluke origin to immunise against parasitic infestation of helminths in mammals
DK1095141T3 (da) Fremgangsmåde til fremstilling af et peptid med pI-værdi over 8 eller under 5
ES2134430T3 (es) Procedimiento de fluoracion.
FI944560A0 (fi) Menetelmiä oleellisesti puhtaan EG III -sellulaasin tuottamiseksi alkoholia käyttäen
ATE319837T1 (de) Verfahren zur herstellung von rekombinantem trypsin
DE69829282D1 (de) Verfahren zur herstellung von optisch aktiven alkoholen
TR27897A (tr) Etanol ve izopropanol üretmeye mahsus yöntem.
IT1286523B1 (it) Processo per la preparazione di un amminoalcol
DE69403464D1 (de) Herstellung von glycolate-oxydase in methylotrophen hefen
DK85892A (da) Forbraendingsmotordrevet hoejtryksrenser
ATE231887T1 (de) Protein mit anti-tumorwirkung
EA199800028A1 (ru) Винилсульфоксиды и способы их синтеза
FI940684A (fi) Menetelmä Streptococcus suis -bakteerin adhesiiniproteiinin ja sen vasta-aineen valmistamiseksi